Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain
- 27 December 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 271 (2-3), 515-523
- https://doi.org/10.1016/0014-2999(94)90813-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agentsTrends in Pharmacological Sciences, 1993
- WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptorsEuropean Journal of Pharmacology, 1993
- (S)-N-tert-Butyl-3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptorsJournal of Medicinal Chemistry, 1993
- Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomographySynapse, 1992
- Concepts for the design of 5‐HT1A serotonin agonists and antagonistsDrug Development Research, 1992
- Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic studyBrain Research, 1991
- The Central 5‐HT1A Receptors: Pharmacological, Biochemical, Functional, and Regulatory PropertiesaAnnals of the New York Academy of Sciences, 1990
- The curvilinear scatchard plotBiochemical Pharmacology, 1989
- Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activityProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966